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Echocardiographic contrast microbubbles expand and contract rhythmically
when ultrasound energy is applied to them. These oscillations generate
sound waves not only at the primary or input frequency, but also at higher
harmonic frequencies. Solid tissues do not generally produce strong har-
monic signals, thus the detection of higher harmonic frequencies is relatively
specific for echocardiographic contrast agents. We therefore examined the
imaging characteristics of various contrast agents using a novel echocar-
diographic system producing images from second harmonic signals (Con-
trast Specific Imaging, Acuson). As anticipated, unenhanced tissues were
poorly seen in this imaging mode, while contrast containing structures were
clearly visualized. Agent-specific differences in image appearance and sig-
nal strength following contrast administration were identified. Second har-
monic imaging improved detection of small concentrations of contrast. Small
contrast containing structures were more clearly resolved than with conven-
tional imaging. Intracavitary blood flow patterns were observed. Time inten-
sity curves generated during administration of contrast media were similar
for conventional and second harmonic imaging. Cardiac cycle-dependent
changes in second harmonic signal intensity were noted.
Conclusions: Second harmonic imaging provides excellent visualization of
structures containing ultrasonic contrast agents. The intensity and appear-
ance of the contrast effect observed with the Contrast Specific Imaging sys-
tem is dependent upon the size and composition of the microbubbles. Tun-
ing of the second harmonic imaging system to the specific contrast agent
may be useful to optimize contrast detection.
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We have previously demonstrated the formulation of acoustic multilamel-
lar liposomes that does not require gas entrapment. Successful antibody
conjugation of Iiposomes, while retaining acoustic properties, could pro-
vide an ultrasonic contrast agent for the early detection of atherosclerosis,
thrombi, and vegetations. We prepared Iiposomes from a (55: 10: 5 : 301
molar mixture of egg phosphatidylcholine, 4-(p-maleimidophenyllbutyryl-
phosphatidylethanolamine, dipalmitoyalphosphatidylglycerol, and choles-
terol by hydration of the lipid film and sonication followed by freeze dry-
ing and resuspension. Human gamma globulin was thiolated for conjugation
to the liposomes with N-succinimidyI3-(2-pyridyldithiolpropionate. Following
reaction, the unbound antibody was removed by separation on a Sepharose
4B column. To determine acoustic properties, the conjugated preparation
was imaged with a 20 mHz intravascular ultrasound catheter (Cardiovascular
Imaging System, Sunnyvale, CAl and compared to water and our previously
unconjugated Iiposomes.
Results: This method allowed near complete conjugation of Iiposomes.
The average liposomal size following antibody conjugation was 0.5 Ilm.
Gray Scale brightness (mean) and heterogeneity.
ECHOCARDIOGRAPHY - NEW INSTRUMENTATION
Second Harmonic Imaging of Echocardiographic
Contrast Agents: Unique Features and Promising
Characteristics
David A. Foley, Sharon L. Mulvagh, Beat C. Aeschbacher, Kyle K. Klarich, James
B. Seward. Mayo Clinic and Mayo Foundation. Rochester. MN
Magnitude of brightness b vs. water in dB (2010g[lipo/water]) was 14.5 for
unconjugated and 12.7 for conjugated Iiposomes.
We have demonstrated a method of antibody conjugation to liposomes
that allows the liposomes to retain their acoustic reflectivity. This novel tech-
nique allows for target-specific in-vivo acoustic enhancement of pathologic
vascular structures.
ficity. The presence of both O-waves and T-inversion in aVF was diagnostic
with a specificity of 100% though a low sensitivity of 13%.
Conclusion. The presence of either a O-wave or T-inversion in aVF appears
to be useful in predicting past inferior infarction in patients with LBBB. The
combination of the two, though rare, has a high positive predictive value.
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New Criteria for the Diagnosis of Inferior
Infarction In Patients with Left Bundle Branch
Block
ABSTRACTS
OT dispersion (OTO = OT max - OT min), measured from the 12-lead ECG,
reflects regional variations in ventricular repolarization and has been associ-
ated with an increased risk of arrhythmic events in some patient Iptl groups,
but has not been applied as a predictor in patients at risk for recurrent, sus-
tained ventricular tachyarrhythmias (VTNF). Thus, we sought to determine
the predictive value of OTO in consecutive pts presenting with life threaten-
ing ventricular arrhythmias and treated with antiarrhythmic drugs predicted
to be effective by electrophysiologic testing (n = 11 )or Holter monitoring In
= 18). Methods: The study group comprised 29 pts of age 66 ± 13 years with
ejection fraction 37 ± 13%; 24 were males, 23 had coronary artery disease;
22 had failed previous antiarrhythmic therapy; treatment was with class I
drugs in 16 and class III (sotaloll in 13. Follow-up lasted up to 5.7 years Ix ±
SO, 2.1 ± 1.7). Arrhythmia recurred in 15 pts; there were 4 arrhythmic and
7 total deaths. Parameters on 12 lead ECG tested for long-term predictive
value included ORS, OT. OTc, JT, JTc, OTO, OTcO, JTO, and JTcO. Measure-
ments were made within 1 mo of initiating "effective" antiarrhythmic therapy
by an experienced observer using electronic calipers and blinded to clinical
course. Results: Only measures of dispersion of recovery were predictors
of arrhythmic and total mortality: OTO (p :::: 0.005, 0.0001), OTcO (p :::: 0.01,
0.0001). JTD (p :::: 0.005, 0.0000), and JTcO(p:::: 0.005, 0.00001. In patients dy-
ing vs surviving, OTO was 147 :::: 42 vs 74 :::: 34 ms and JTcO, 141 :::: 33 vs 76
± 30 ms, respectively. Predictive value was independent of antiarrhythmic
therapy (ie, sotalol vS other) in a multivariate model. Thus, excessive disper-
sion of repolarization is a powerful predictor of arrhythmic and total deaths,
despite "effective" drug therapy, in patients with life-threatening ventricular
arrhythmias. OTO should be further tested in larger groups of high-risk pts,
including the selection of pts for further therapies (eg, defibrillators).
QT Dispersion Predicts Mortality in Treated
Patients with Life-threatening Ventricular
Tachyarrhythmias
Labros A. Karagounis, Jeffrey L. Anderson. University of Utah. LDS Hospital, Salt Lake
City. Utah
Charles L. Laham, Stephen C. Hammill, Raymond J. Gibbons. Mayo Clinic,
Rochester. MN
The ability to diagnose inferior infarction in patients with left bundle branch
block (LBBB) is limited by the lack of established criteria. To develop cri-
teria, the ECGs of 187 patients with LBBB who had either normal results
(Normals) or an isolated, unequivocal inferior infarct (IMI) on stress thallium
testing were examined. Patients with acute IMI within 30 days of the thal-
lium were excluded. LBBB was defined as ORS duration 2: 120 msec with
the classic patterns of ORS/T changes in leads I, aVL. V5, and V6. O-waves
were significant if they were 2:30 msec in duration and 25% the height of the
R-wave; T-waves were considered inverted if they were either totally nega-
tive or biphasic with initial negative deflection. Results:
subcutaneous monitoring device (Medtronic, Inc.) in 14 patients (m age 57 ±
21 yrsl with 7.3 ± 4.6 previous syncopal episodes and negative AM, head up
tilt(HUT) and EP studies. The pacemaker-shaped device has 2 electrodes 3.2
cm. apart and is able to record 7.5 or 15 minutes of continuous ECG signal
in a circular buffer, which is triggered by magnet application by the patient or
partner. The data are then retrievable by telemetry. Eight patients had struc-
tural heart disease. Eleven patients developed recurrent syncope 4.1 ± 4.3
months after implantation.
The etiology of syncope was bradycardic in 5 (sinus arrest in 3, complete
heart block in 2), tachyarrhythmic in 2 (Supraventricular tachycardia in 1, ven-
tricular tachycardia in 1), and non-arrhythmic in 4 (vasodepressor in 2, hemo-
dynamic in 1, and psychogenic in 1). No further episodes of syncope have
occurred over 10.3 ± 7.6 months follow-up after successful therapy was im-
plemented in alill patients. The remaining 3 patients have not had recurrent
syncope over a mean of 8.7 months and continue to be followed.
Conclusions: We conclude that patients with SUE after negative investiga-
tions have a broad spectrum of etiologies, with bradycardia being the most
common. The etiology of syncope is often not apparent from clinical vari-
ables. An implantable "loop recorder" is useful for making a diagnosis when
episodes are too infrequent for standard ambulatory monitoring techniques.
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The presence of diagnostic O-waves or T-inversion in aVF was found to be
predictive of IMI in patients with LBBB with 85% sensitivity and 86% speci-
